Acute Renal Failure (ARF) Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $9.02 Billion
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Acute Renal Failure (ARF) Market?
The market for acute renal failure (arf) has seen substantial growth in recent years, with the market set to expand from $6.09 billion in 2024 to $6.6 billion in 2025, a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this impressive growth during the historic period include an increase in the aging population, a rise in sepsis occurrences, enhanced diagnostic abilities, government initiatives towards healthcare, and escalating instances of nephrotoxic medication.
Expectations are high for strong expansion in the acute renal failure (arf) market over the forthcoming years. Forecasts predict it will soar to $9.02 billion by 2029, progressing at a compound annual growth rate (CAGR) of 8.1%. This growth trajectory during the forecast period can be credited to burgeoning home-based dialysis solutions and emerging markets, evolving renal biomarkers, research and development of new therapeutic drugs, and an increased requirement for non-invasive diagnostics. Key trends projected within this period include advancements in continuous renal replacement therapy (CRRT), 3D bioprinting of renal tissue, adoption of wearable biosensors, the advent of next-generation dialysis machines and drug delivery powered by nanotechnology.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21083&type=smp
What Drivers Are Accelerating Expansion Of The Acute Renal Failure (ARF) Market?
The escalating incidence of chronic kidney ailments is anticipated to bolster the acute renal failure (ARF) market’s expansion in the future. Chronic kidney disease (CKD) denotes a persistent condition in which the kidneys sustain damage, impairing their ability to filter blood effectively. This upsurge in chronic kidney disease cases stems from increasing instances of diabetes, hypertension, obesity, an aging global population, and lifestyle-related elements. Acute renal failure, manifested by an abrupt kidneys’ function loss, can serve as a major catalyst or worsening element for chronic kidney disease by inflicting irreversible harm to kidney tissues, compromising filtration efficacy, and elevating the threat of ongoing, long-term kidney malfunction if mishandled. For example, a report by Kidney Research UK, a UK-based non-profit organization, revealed in June 2023 that around 7.2 million people, or over 10% of the UK’s population, are currently enduring chronic kidney disease. Of these patients, 3.25 million experience the disease’s advanced stages, while 3.9 million are in the preliminary stages. By 2033, the number of people afflicted by chronic kidney disease is estimated to surge to 7.61 million. Hence, the rising incidence of chronic kidney diseases propels the acute renal failure (ARF) market’s growth.
What Are The Primary Segmentation Parameters In The Acute Renal Failure (ARF) Market?
The acute renal failure (arf)market covered in this report is segmented –
1) By Disease Type: Prerenal Acute Renal Failure; Renal Acute Renal Failure; Postrenal Acute Renal Failure
2) By Drug Type: Diuretics; Vasopressors; Erythropoiesis-Stimulating Agents (ESAS); Phosphate Binders; Calcium and Vitamin D Supplements; Antibiotics; Others Drugs
3) By Route of Administration: Oral; Intravenous
4) By Diagnosis: Computed Tomography (CT) Scan; Kidney Biopsy; Ultrasound
5) By End-Users: Clinics; Hospitals; Home Healthcare; Others End-Users
Subsegments:
1) By Prerenal Acute Renal Failure: Hypovolemia; Decreased Cardiac Output; Renal Artery Stenosis
2) By Renal Acute Renal Failure: Acute Tubular Necrosis; Glomerulonephritis; Interstitial Nephritis
3) By Postrenal Acute Renal Failure: Obstructive Uropathy; Bladder Outlet Obstruction; Kidney Stones
How Are Market Trends Influencing Competition In The Acute Renal Failure (ARF) Market?
Key players in the acute renal failure (ARF) market are concentrating on securing regulatory approvals for drug products in order to extend their market presence and fortify their standing in delivering treatments for serious acute kidney injury (AKI). Such approvals entail official authorization from government or regulatory entities authorizing the application and distribution of drugs, medical devices, or therapies. For instance, in February 2024, CalciMedica, a clinical-stage biopharmaceutical firm based in the US, obtained FDA clearance for an IND application to initiate a Phase 2 trial of Auxora. This trial will assess the effectiveness of Auxora in treating severe AKI associated with acute hypoxemic respiratory failure (AHRF), a condition with a high rate of mortality. The KOURAGE trial is an organized, double-blind, placebo-controlled study aiming to recruit approximately 150 patients suffering from Stage 2 and 3 AKI, who are also dealing with AHRF. The study will analyze the efficacy of Auxora over a course of five daily doses by measuring the number of days patients survive without the requirement for mechanical ventilation or kidney dialysis up to 30 days after treatment.
Which Players Are Shaping The Competitive Landscape Of The Acute Renal Failure (ARF) Market?
Major companies operating in the acute renal failure (ARF) market are Pfizer Inc., Novartis AG, LG Chem Ltd., Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Baxter International Inc., Astellas Pharma Inc., Syensqo, Dr. Reddy’s Laboratories Limited, Zydus Lifesciences Limited, NIKKISO Co., Ltd., Quark Pharmaceuticals Inc., NIPRO Corporation, Alloksys Life Sciences B.V., AM-Pharma B.V., Sentien Biotechnologies, MediBeacon LLC, Angion Biomedica Corp., Atox Bio Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/acute-renal-failure-arf-global-market-report
What Are The Emerging Regional Trends Driving The Acute Renal Failure (ARF) Market?
North America was the largest region in the acute renal failure (ARF) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute renal failure (ARF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21083&type=smp
Browse Through More Reports Similar to the Global Acute Renal Failure (ARF) Market 2025, By The Business Research Company
Renal Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
End Stage Renal Disease Esrd Drug Global Market Report 2025
Hepatorenal Syndrome Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
